N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

Sponsor: Helsinki University Central Hospital • ClinicalTrials.gov ID: NCT06123117

Registry updated: 2026-10-05
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This trial is a prospective randomized superiority trial comparing sole ropivacaine based local trocar site infiltration to local infiltration combined with laparoscopic ropivacaine TAP block (STALL) in LCC. There are only a few randomized trials comparing sole local anesthesia to additional laparoscopic TAP block in laparoscopic cholecystectomy and they have yet failed to show evidence in favor of TAP block. We hypothesize STALL (Single Transversus Abdominis Laparoscopy-guided plane block combined with Local trocar site ropivacaine infiltration) is superior to local port site infiltration, provided that the sample size is sufficiently big. The aim of this randomized study is to compare the efficacy of sole local anesthesia of trocar sites to STALL in LCC.

Interventions

  • single transversus abdominis laparoscopy-guided plane block (Procedure)
    please see arm/group descriptions
  • local trocar site ropivacaine infiltration (Procedure)
    please see arm/group descriptions

Eligibility criteria

Inclusion Criteria: * All patients scheduled for elective or emergency LCC, aged over 18 and able to give an informed consent. Exclusion Criteria: * Age under 18 years, chronic daily opioid and/or pain tolerance / pain threshold -modifying medication use (abuse), pregnancy, known allergy to local anesthetics, diagnosed severe coagulopathy and incapability to give informed consent for whatever reason.

Conditions

Cholelithiasis Cholecystitis Gallbladder Cancer

Locations

  • Jorvi hospital / HUS — Espoo, Uusimaa, Finland
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record